(Q43450754)

23 November 2017

title

A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy (English)

1 reference

23 November 2022

1 reference

23 November 2022

author name string

M. Katano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

E. Kubota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

H. Yamamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

M. Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

T. Matsuo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

T. Hisatsugu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

T. Katsuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

H. Koga

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

K. Ikezaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

K. Tabuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786201

23 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1786201

23 November 2022

publication date

1 January 1991

1 reference

full work available at URL

23 November 2017

http://link.springer.com/content/pdf/10.1007/BF02221331.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02221331/fulltext.html

23 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02221331

23 November 2022

1 reference

Biotherapy (Dordrecht, Netherlands)

23 November 2022

published in

1 reference

23 November 2017

volume

3

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

373-379

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02221331

23 November 2017

exact match

0 references

cites work

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1

1 reference

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

23 November 2022

3

1 reference

Immunotherapy of cancer using interleukin 2: current status and future prospects

23 November 2022

4

1 reference

Structure and expression of a cloned cDNA for human interleukin-2.

23 November 2022

6

1 reference

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

23 November 2022

7

1 reference

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

23 November 2022

8

1 reference

Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.

23 November 2022

10

1 reference

Streptococcal preparation OK-432-induced interferon in human leukocytes: purification and characterization

23 November 2022

11

1 reference

Augmentation of interleukin 1 and interleukin 2 production by OK-432

23 November 2022

12

1 reference

Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation

23 November 2022

13

1 reference

Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation

23 November 2022

14

1 reference

A two-site sandwich radioimmunoassay of human gamma interferon with monoclonal antibodies

23 November 2022

17

1 reference

Primary Bioassay of Human Tumor Stem Cells

23 November 2022

18

1 reference

Colony-forming ability in vitro and clonology of colorectal cancer.

23 November 2022

19

1 reference

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

23 November 2022

20

1 reference

Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha

23 November 2022

24

1 reference

Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma

23 November 2022

26

1 reference

The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF)

23 November 2022

27

1 reference

23 November 2022

Identifiers

DOI

10.1007/BF02221331

1 reference

Dimensions Publication ID

23 November 2017

1051536715

0 references

1 reference